The American Academy of Pediatrics published its updated RSV immunisation policy statement on 2 September, alongside a technical report setting out the evidence. This is the substantive regulatory item today; the paediatrics drug approval and enforcement feeds returned nothing at all, which is usual — drug regulators rarely publish anything paediatricians act on directly.
The core recommendation is unchanged in structure. All infants under 8 months of age born during or entering their first RSV season should receive RSV immunisation, unless the infant has documented protection from vaccination of the pregnant parent. Infants and children aged 8 through 19 months who are at high risk of severe RSV disease and entering their second season should also be immunised.
What has changed is the second-season group. The AAP states that a review of evidence supports expanding the high-risk criteria for children aged 8 through 19 months, with the detail in the accompanying technical report. Practically, that means more toddlers with chronic lung disease, congenital heart disease, severe immunocompromise or neuromuscular conditions will now qualify — and the operational task is identifying them before the season rather than during it.
The either-or structure is worth stating plainly to families, because it is the most frequently misunderstood part. Maternal vaccination and infant monoclonal antibody are alternative routes to the same protection, not a course to be completed. An infant whose mother was vaccinated at the right gestation does not need the antibody as well.
- Immunise all infants under 8 months entering their first RSV season unless the pregnant parent was vaccinated with documented protection
- Review the expanded high-risk criteria for children aged 8 to 19 months entering a second season, and identify those children before the season begins
- Explain to families that maternal vaccination and infant antibody are alternatives, not a two-part course
- Record maternal RSV vaccination status in the infant's notes so the decision is not repeated at every contact
- Note the coverage gap: Indian Academy of Pediatrics and WHO guidance and CDSCO notices do not reach this feed
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for paediatrics, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free